Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection

In the present study, immunogenicity data in 61 vaccinated healthcare workers (HCWs) either infection naïve (naïve HCWs) or with infection of Delta and/or Omicron COVID-19 (experienced HCWs) were evaluated up to 270 days after the second dose of BNT162b2 vaccine and up to 90 days after a booster dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Vietri, Maria Teresa, D'Elia, Giovanna, Caliendo, Gemma, Passariello, Luana, Albanese, Luisa, Molinari, Anna Maria, Angelillo, Italo Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411148/
https://www.ncbi.nlm.nih.gov/pubmed/36041940
http://dx.doi.org/10.1016/j.vaccine.2022.08.045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411148/
https://www.ncbi.nlm.nih.gov/pubmed/36041940
http://dx.doi.org/10.1016/j.vaccine.2022.08.045

Ejemplares similares